Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

MGX

Metagenomi Therapeutics, Inc.

CIK 0001785279 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$1.23
↑ 0.03 (2.50%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$46.47M
P/E Ratio
-0.50
EPS
-2.36
Dividend Yield
Not covered
52W Position
4%
Beta
1.58

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.41
P/S
Not covered
EV/Revenue
Not covered
ROE
-83.0%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 4%
$1.13$3.95

Latest Financials

2025-12-31 FY
Revenue
$25.21M
Net Income
-$87.87M
Total Assets
$221.10M
Free Cash Flow
-$89.47M

Recent news